Lithium

Mineral Resources' stock faces a 50% decline as shareholders express concerns over governance and market challenges.

2024-11-21T03:51:00+0000

Arcadium reports a revenue dip to $255 million due to soft lithium demand, while Neuron Pharmaceuticals enjoys a royalty boost, signaling mixed market conditions and strategic adaptations in the face of global economic challenges.

2024-08-08T01:40:23+0100

Pilbara Minerals shares have sunk with the lithium price, but CEO Dale Henderson is pressing on with expansion plans. Where next?

2024-02-09T22:02:44+0000

Your ASX 200 afternoon report.

2024-01-23T03:45:12+0000

Pilbara Minerals' profit plunged 89% to $257 million as lithium prices tumbled. Revenue dropped 69% to $1.2 billion, and the company secured a $1 billion debt facility.

2024-08-27T06:35:07+0100